IRWD
Ironwood Pharmaceuticals Inc
Price:  
3.72 
USD
Volume:  
2,103,490.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IRWD WACC - Weighted Average Cost of Capital

The WACC of Ironwood Pharmaceuticals Inc (IRWD) is 6.1%.

The Cost of Equity of Ironwood Pharmaceuticals Inc (IRWD) is 9.00%.
The Cost of Debt of Ironwood Pharmaceuticals Inc (IRWD) is 4.40%.

Range Selected
Cost of equity 7.90% - 10.10% 9.00%
Tax rate 6.30% - 17.50% 11.90%
Cost of debt 4.00% - 4.80% 4.40%
WACC 5.6% - 6.7% 6.1%
WACC

IRWD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.88 0.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 10.10%
Tax rate 6.30% 17.50%
Debt/Equity ratio 1.27 1.27
Cost of debt 4.00% 4.80%
After-tax WACC 5.6% 6.7%
Selected WACC 6.1%